These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1895978)

  • 1. Failure to demonstrate contrast nephrotoxicity.
    Heller CA; Knapp J; Halliday J; O'Connell D; Heller RF
    Med J Aust; 1991 Sep; 155(5):329-32. PubMed ID: 1895978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
    Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
    Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of high- and low-osmolality contrast media on renal function in children].
    Chen CY; Cao L; Chen DK; Chu M; Tu J
    Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):280-4. PubMed ID: 16780650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents.
    Harris KG; Smith TP; Cragg AH; Lemke JH
    Radiology; 1991 Jun; 179(3):849-52. PubMed ID: 2028004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
    Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
    Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
    Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
    Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
    Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
    JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media.
    Barrett BJ; Parfrey PS; Vavasour HM; McDonald J; Kent G; Hefferton D; O'Dea F; Stone E; Reddy R; McManamon PJ
    Kidney Int; 1992 May; 41(5):1274-9. PubMed ID: 1614041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model.
    Duan SB; Wang YH; Liu FY; Xu XQ; Wang P; Zou Q; Peng YM
    Acta Radiol; 2009 Sep; 50(7):754-9. PubMed ID: 19452295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial.
    Davidson CJ; Hlatky M; Morris KG; Pieper K; Skelton TN; Schwab SJ; Bashore TM
    Ann Intern Med; 1989 Jan; 110(2):119-24. PubMed ID: 2909204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study.
    Cely CM; Schein RM; Quartin AA
    Crit Care; 2012 Dec; 16(2):R67. PubMed ID: 22534554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
    Hunter TB; Dye J; Duval JF
    AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
    Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
    Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
    Moore RD; Steinberg EP; Powe NR; Brinker JA; Fishman EK; Graziano S; Gopalan R
    Radiology; 1992 Mar; 182(3):649-55. PubMed ID: 1535876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
    Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
    Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental histopathological studies of renal lesions induced by high- or low-osmolality contrast media].
    Niu G
    Nihon Ika Daigaku Zasshi; 1993 Dec; 60(6):390-405. PubMed ID: 8276921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.